Happens sometimes that pharmaceutical companies sell products that have not been the subject of sufficient evidence on possible adverse effects in patients, or simply that they eventually manifest itself in a very distant time horizon, spent years since its launch in circulation and the appearance of the first cases of people affected by them. In particular heart and cardiovascular system which is part, in general, are among the parts of our anatomy that are most sensitive to this type of cases of defective drugs. And it is that this works as a precision clock, and any minimum disturbance or exposure to dangerous or harmful substances could prove fatal. The responsibility of pharmaceutical companies could cite various examples of drugs that are potentially dangerous for our cardiovascular system. A first very illustrative case would be that of the Phen Fen, composite employee specifically in diets and which allowed to reduce the appetite of the patient and increase your feeling of satiety; determining subsequent that it gave rise to problems such as hypertension or disease in the heart valves.
Another case would be that of Ortho Evra, a birth control patch that had very similar to pill effects but which was completed by verifying that it could lead to stroke, heart failure, or blood clots. The factor common to them is none other than the responsibility of the pharmaceutical company that made them or distributed, constituting cases of liability for defective products. And it is that any company that puts a product on the market assumes, according to regulations, the obligation that it be safe according to the uses for which they had been designed, and must be collected in a list of instructions and indications details that allow consumer 0,006 without risk to your health your safety. Any breach of such an obligation would result in such company obligation of repair the damage caused to him, if it is personal as if is equity.